What are the Challenges Associated with Targeting Differentiation Antigens?
While targeting differentiation antigens offers significant therapeutic potential, there are challenges. One major issue is the potential for autoimmunity, where the immune system might also attack normal cells expressing low levels of these antigens. Additionally, the heterogeneity of antigen expression within the tumor can lead to incomplete eradication of cancer cells, necessitating combination therapies or multiple targets.
